TG Therapeutics | TGTX - Ordinary Share Capital



TG Therapeutics reported $158.02M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
AbbVie USD 18M 0 Dec/2024
Alaunos Therapeutics USD 2K 0 Dec/2024
Amgen USD 538M 33.04B Jun/2025
Ardelyx USD 240.77M 240.74M Jun/2025
Arrowhead Research USD 138.14M 137.91M Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Corcept Therapeutics USD 105.29M 105.15M Jun/2025
Dynavax Technologies USD 117.23M 117.11M Jun/2025
Gilead Sciences USD 1.24B 3M Jun/2025
J&J USD 3.12B 0 Mar/2025
Novartis USD 793M 0 Dec/2024
PTC Therapeutics USD 79.38M 79.3M Jun/2025
Regeneron Pharmaceuticals USD 106.4M 106.4M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
TG Therapeutics USD 158.02M 157.87M Jun/2025
Vertex Pharmaceuticals USD 256.3M 253.7M Jun/2025